80 related articles for article (PubMed ID: 23002055)
21. Elevated expression of Foxp3 in tumor-infiltrating Treg cells suppresses T-cell proliferation and contributes to gastric cancer progression in a COX-2-dependent manner.
Yuan XL; Chen L; Li MX; Dong P; Xue J; Wang J; Zhang TT; Wang XA; Zhang FM; Ge HL; Shen LS; Xu D
Clin Immunol; 2010 Mar; 134(3):277-88. PubMed ID: 19900843
[TBL] [Abstract][Full Text] [Related]
22. Sorafenib relieves cell-intrinsic and cell-extrinsic inhibitions of effector T cells in tumor microenvironment to augment antitumor immunity.
Chen ML; Yan BS; Lu WC; Chen MH; Yu SL; Yang PC; Cheng AL
Int J Cancer; 2014 Jan; 134(2):319-31. PubMed ID: 23818246
[TBL] [Abstract][Full Text] [Related]
23. Changes of Th17/Tc17 and Th17/Treg cells in endometrial carcinoma.
Zhang W; Hou F; Zhang Y; Tian Y; Jiao J; Ma D; Kong B; Cui B
Gynecol Oncol; 2014 Mar; 132(3):599-605. PubMed ID: 24388919
[TBL] [Abstract][Full Text] [Related]
24. CD39+Foxp3+ regulatory T Cells suppress pathogenic Th17 cells and are impaired in multiple sclerosis.
Fletcher JM; Lonergan R; Costelloe L; Kinsella K; Moran B; O'Farrelly C; Tubridy N; Mills KH
J Immunol; 2009 Dec; 183(11):7602-10. PubMed ID: 19917691
[TBL] [Abstract][Full Text] [Related]
25. Foxp3(+) regulatory T cells and natural killer cells distinctly infiltrate primary tumors and draining lymph nodes in pulmonary adenocarcinoma.
Schneider T; Kimpfler S; Warth A; Schnabel PA; Dienemann H; Schadendorf D; Hoffmann H; Umansky V
J Thorac Oncol; 2011 Mar; 6(3):432-8. PubMed ID: 21258248
[TBL] [Abstract][Full Text] [Related]
26. Selective infiltration of CCR5(+)CXCR3(+) T lymphocytes in human colorectal carcinoma.
Musha H; Ohtani H; Mizoi T; Kinouchi M; Nakayama T; Shiiba K; Miyagawa K; Nagura H; Yoshie O; Sasaki I
Int J Cancer; 2005 Oct; 116(6):949-56. PubMed ID: 15856455
[TBL] [Abstract][Full Text] [Related]
27. LAP+CD4+ T cells are suppressors accumulated in the tumor sites and associated with the progression of colorectal cancer.
Mahalingam J; Lin YC; Chiang JM; Su PJ; Fang JH; Chu YY; Huang CT; Chiu CT; Lin CY
Clin Cancer Res; 2012 Oct; 18(19):5224-33. PubMed ID: 22879386
[TBL] [Abstract][Full Text] [Related]
28. Prediction of recurrence and survival in hepatocellular carcinoma based on two Cox models mainly determined by FoxP3+ regulatory T cells.
Lin SZ; Chen KJ; Xu ZY; Chen H; Zhou L; Xie HY; Zheng SS
Cancer Prev Res (Phila); 2013 Jun; 6(6):594-602. PubMed ID: 23599540
[TBL] [Abstract][Full Text] [Related]
29. IL-10 suppresses Th17 cells and promotes regulatory T cells in the CD4+ T cell population of rheumatoid arthritis patients.
Heo YJ; Joo YB; Oh HJ; Park MK; Heo YM; Cho ML; Kwok SK; Ju JH; Park KS; Cho SG; Park SH; Kim HY; Min JK
Immunol Lett; 2010 Jan; 127(2):150-6. PubMed ID: 19895848
[TBL] [Abstract][Full Text] [Related]
30. Pi (Spleen)-deficiency syndrome in tumor microenvironment is the pivotal pathogenesis of colorectal cancer immune escape.
Sun XG; Lin XC; Diao JX; Yu ZL; Li K
Chin J Integr Med; 2016 Oct; 22(10):789-94. PubMed ID: 26556710
[TBL] [Abstract][Full Text] [Related]
31. [Inflammation and cancer - colorectal carcinoma as an example].
Väyrynen J; Böhm J
Duodecim; 2016; 132(2):137-44. PubMed ID: 26939486
[TBL] [Abstract][Full Text] [Related]
32. Risk factors: Immune tolerance confers cancer risk.
Sidaway P
Nat Rev Clin Oncol; 2015 Oct; 12(10):564. PubMed ID: 26346843
[No Abstract] [Full Text] [Related]
33. Functional impairment of infiltrating T cells in human colorectal cancer.
Taylor ES; McCall JL; Girardin A; Munro FM; Black MA; Kemp RA
Oncoimmunology; 2016; 5(11):e1234573. PubMed ID: 27999752
[TBL] [Abstract][Full Text] [Related]
34. [Analysis of the Tumor Immune Microenvironment of Colorectal Cancer by Deep Learning-Based Imaging Cytometry].
Yamashita K; Nagasaka T; Adachi Y; Abe T; Kakeji Y
Gan To Kagaku Ryoho; 2023 Sep; 50(9):955-957. PubMed ID: 37800286
[TBL] [Abstract][Full Text] [Related]
35. IL-22-mediates Cross-talk between Tumor Cells and Immune Cells Associated with Favorable Prognosis in Human Colorectal Cancer.
Droeser RA; Iezzi G
J Cell Immunol; 2021; 3(2):118-121. PubMed ID: 34296212
[TBL] [Abstract][Full Text] [Related]
36. Hunting for clues: Regulatory T cells and colorectal cancer.
Gallimore A; Godkin A
Oncoimmunology; 2012 Oct; 1(7):1163-1164. PubMed ID: 23170265
[TBL] [Abstract][Full Text] [Related]
37. Need for early, minimally invasive cancer diagnosis.
Paraskevaidi M; Martin-Hirsch PL; Martin FL
Proc Natl Acad Sci U S A; 2019 Mar; 116(11):4752. PubMed ID: 30782793
[No Abstract] [Full Text] [Related]
38. Reply to Paraskevaidi et al.: Epithelial and microenvironment characterization is key to understanding and improving diagnoses.
Yeh K; Mittal S; Bhargava R
Proc Natl Acad Sci U S A; 2019 Mar; 116(11):4753-4754. PubMed ID: 30782792
[No Abstract] [Full Text] [Related]
39. Current and Prospective Methods for Assessing Anti-Tumor Immunity in Colorectal Cancer.
Nussbaum YI; Manjunath Y; Suvilesh KN; Warren WC; Shyu CR; Kaifi JT; Ciorba MA; Mitchem JB
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33946558
[TBL] [Abstract][Full Text] [Related]
40. Molecular features and gene expression signature of metastatic colorectal cancer (Review).
Poturnajova M; Furielova T; Balintova S; Schmidtova S; Kucerova L; Matuskova M
Oncol Rep; 2021 Apr; 45(4):. PubMed ID: 33649827
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
